Mitigating Pandemic Impact: A Systematic Model for Public Health Action |Chapter 5 | An Overview of Disease and Health Research Vol. 7

 

Population growth, as well as the current ease of global interconnectedness, has created an environment conducive to the rapid emergence and spread of infectious diseases, posing a significant threat to global health security. This document describes a systematic framework for the containment and management of these threats, focusing on the principles of Emergency Preparedness, Resilience, and Response (EPRR). The initial and therefore most critical containment barrier is the effective surveillance of primary care physicians, who must maintain a high level of suspicion to detect unusual or epidemiologically suspicious cases. The response to this type of crisis includes the immediate isolation of patients with suspected or confirmed disease, infection control measures, and rapid reporting, all of which are crucial to gain as much time as possible and thus prevent further transmission of the pathogen. If infections cannot be contained, an Outbreak Control Team is deployed to lead a public health response that integrates epidemiology, logistics, and risk communication. The strategic measures required at different levels of care are also detailed, ranging from adapting hospital workflows and managing resource shortages to orienting primary care to manage large patient volumes. Emphasis is placed on the use of traditional public health tools such as screening, isolation, contact tracing, and social distancing in the face of the uncertainty generated by the crisis. The conclusion of the acute phase then gives way to a crucial stage of recovery and learning from the experience, where a structured post-incident review and ongoing training strengthen the future resilience of systems. This approach, with its three proposed interdependent pillars, is intended to be the cornerstone for society's adaptation to the unpredictable nature of biological crises.

 

 

Author(s) Details

Miztli David Aguilar-Caballero
Department of Research and Technological Development, Directorate of Teaching and Research, Institute of Public Health from Guanajuato State, Guanajuato, Mexico.

 

Juan Pablo Becerra-Martinez
Department of Research and Technological Development, Directorate of Teaching and Research, Institute of Public Health from Guanajuato State, Guanajuato, Mexico.

 

Ma Guadalupe León-Verdín
Department of Research and Technological Development, Directorate of Teaching and Research, Institute of Public Health from Guanajuato State, Guanajuato, Mexico.

 

Maria de Jesus Gallardo-Luna
Department of Research and Technological Development, Directorate of Teaching and Research, Institute of Public Health from Guanajuato State, Guanajuato, Mexico.

 

Efraín Navarro-Olivos
Directorate of Teaching and Research, Institute of Public Health from Guanajuato State, Guanajuato, Mexico.

 

Leticia Zamora-Ramos
General Directorate of Medical Care, Institute of Public Health from Guanajuato State, Guanajuato, Mexico.

 

Nicolas Padilla-Raygoza
Department of Research and Technological Development, Directorate of Teaching and Research, Institute of Public Health from Guanajuato State, Guanajuato, Mexico.

 

Please see the book here :- https://doi.org/10.9734/bpi/aodhr/v7/6536

Biosafety Practices in Mycobacteriology Laboratory | Chapter 1 | Research Advances in Microbiology and Biotechnology Vol. 3

 Mycobacterium infection, the causative agent of infection (TB), is classified as a risk group 3 power, which calls for a Biosafety Level 3 lab (BSL-3) for culture, drug susceptibility experiment, and other lab examinations. Access to a safety laboratory endure be restricted to staff appendages and accredited callers. M. tuberculosis can cause laboratory-seized infections. To guarantee adequate infection control, it is important that a comprehensive and strict biosafety tactics is developed and trailed. Such a policy includes patterned rules and regulations for containment, individual protective supplies (PPE), standard operating procedures (SOP) for different workshop tasks, and a transparent structure for managing safe occupied conditions in diagnostic TB workshops. It is well documented that M. tuberculosis can cause lab-acquired contaminations, and the risk of TB among healthcare workers is usually higher than in the general public. M. tuberculosis even looks in the top-ten list of hazardous agents for lab staff. However, the beginning of the TB infection can only be traced to a distinguishing laboratory accident in a youth of cases. The most important route for lab-acquired infections is aerosols. Thus, contamination control efforts need to focus on restricting the generation of aerosols all along laboratory work, for example, through dependable centrifugation and pipetting. For effective infection control, it is critical that a comprehensive and scrupulous biosafety policy is developed, recognized, and followed by the lab staff. The procedure should include patterned rules and regulations for limit; personal protective supplies (PPE); practical training; standard operating processes (SOPs) for all the different workshop tasks, and transparent and clearly defined levels of maturity for establishing and maintaining secure working environments in the diagnostic TB laboratory.

Author(s) Details:

P. Suganthi,
Department of Medical Microbiology, Institute of Basic Medical Sciences, University of Madras, Tharamani Campus, Chennai, Tamil Nadu, India.

B. Usharani,
Department of Biomedical Genetics, Institute of Basic Medical Sciences, University of Madras, Tharamani Campus, Chennai, Tamil Nadu, India.

R. Venkateswari,
Department of Medical Biochemistry, Institute of Basic Medical Sciences, University of Madras, Tharamani Campus, Chennai, Tamil Nadu, India.

M. Muthuraj,
State TB Training and Demonstration Centre, Intermediate Reference Laboratory, Government Hospital for Chest Diseases, Puducherry, India.

Please see the link here: https://stm.bookpi.org/RAMB-V3/article/view/9759